Thus, addressing the challenge of overcoming neuron-specific irreversible damage caused by targeting FMRP requires a nuanced and innovative approach, given FMRP's vital role in both normal neural function and its potential as a therapeutic target in cancer. The gene discussed is FMR1; the disease is cancer.